Health Condition 1: J454- Moderate persistent asthma Health Condition 2: J454- Moderate persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with tamak shawas vegawastha/Bronchial Asthma
Exclusion criteria
Exclusion criteria: Patients having acute exacerbation of asthma at the time of registration Patients having severe persistent asthma as per GINA classification Patients having tuberculosis pneumonia bronchiectasis and SPO2 5 80% Patient having history of any hypersensitivity to any of the ingredient/s of the trial drugs Patients having history of malignancy Hematemesis,on immunotherapy and having any other concomitant systemic illness which required immediate medical intervention Patients receiving Steroid/ Broncho dilator (orally/inhaled) in last 6 hours Pregnant and lactating mothers Patients having bronchial asthma more than 5 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the effect of Haridra Dhupan in improving lung function such as PEFR FEV1 FVC To determine the effect of Haridra Dhupan in improving asthma symptoms and reducing the severity of tamak swasa vegawasthaTimepoint: 5-7 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the effect of Haridra Dhupan on nasal symptoms score To determine the safety of Haridra Dhupan in patients of Tamak Shwasa To determine the effect of Haridra Dhupan in Improving SPO2 oxygen saturationTimepoint: 5-7 minutes | — |
Countries
India
Contacts
Government Ayurvedic College , Nanded Maharashtra